In the last year, the U.S. Food and Drug Administration began publicly acknowledging harm reduction as a legitimate principle within its regulatory framework. Through its Premarket Tobacco Product Application process, companies can gain authorization to sell their products in the U.S. An important distinction here is that these products are not recognized by the FDA as being safe or approved for treatment of tobacco use disorder.